Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing Medical University, 305 Zhongshan East Road, Xuanwu District, Nanjing, 210002, China.
Department of Respiratory and Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, China.
BMC Pulm Med. 2021 Feb 26;21(1):69. doi: 10.1186/s12890-021-01427-4.
Lower respiratory tract (LRT) specimen culture is widely performed for the identification of Aspergillus. We investigated the clinical features and prognosis of patients with Aspergillus isolation from LRT specimens during acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
This is a 6-year single-center, real-world study. 75 cases out of 1131 hospitalized AECOPD patients were positive for Aspergillus. These patients were carefully evaluated and finally diagnosed of pulmonary aspergillosis (PA, 60 cases, 80%) or colonization (15 cases, 20%). Comparisons of clinical data were performed between these two groups. A cox regression model was used to confirm prognostic factors of Aspergillus infection.
The PA group had worse lung function and higher rates of systemic corticosteroid use and broad-spectrum antibiotic use before admission than the colonization group. The PA group had significantly higher in-hospital mortality and 180-day mortality than the colonization group (45% (27/60) vs. 0% (0/15), p = 0.001, and 52.5% (31/59) vs. 6.7% (1/15), p < 0.001, respectively). By multivariable analysis among Aspergillus infection patients, antifungal therapy (HR 0.383, 95% CI 0.163-0.899, p = 0.027) was associated with improved survival, whereas accumulated dose of systemic steroids > 700 mg (HR 2.452, 95% CI 1.134-5.300, p = 0.023) and respiratory failure at admission (HR 5.983, 95% CI 2.487-14.397, p < 0.001) were independently associated with increased mortality. Significant survival differential was observed among PA patients without antifungals and antifungals initiated before and after Aspergillus positive culture (p = 0.001).
Aspergillus isolation in hospitalized AECOPD patients largely indicated PA. AECOPD patients with PA had worse prognosis than those with Aspergillus colonization. Empirical antifungal therapy is warranted to improve the prognosis for Aspergillus infection.
下呼吸道(LRT)标本培养广泛用于鉴定曲霉。我们研究了慢性阻塞性肺疾病急性加重(AECOPD)期间从 LRT 标本中分离出曲霉的患者的临床特征和预后。
这是一项为期 6 年的单中心真实世界研究。在 1131 例住院 AECOPD 患者中,有 75 例曲霉阳性。对这些患者进行了仔细评估,最终诊断为肺曲霉病(PA,60 例,80%)或定植(15 例,20%)。比较了两组患者的临床资料。使用 Cox 回归模型确定曲霉感染的预后因素。
PA 组入院前肺功能更差,全身皮质类固醇和广谱抗生素使用率更高。PA 组的住院死亡率和 180 天死亡率明显高于定植组(45%(27/60)比 0%(0/15),p=0.001;52.5%(31/59)比 6.7%(1/15),p<0.001)。在曲霉感染患者的多变量分析中,抗真菌治疗(HR 0.383,95%CI 0.163-0.899,p=0.027)与生存改善相关,而累积剂量的全身皮质类固醇>700mg(HR 2.452,95%CI 1.134-5.300,p=0.023)和入院时呼吸衰竭(HR 5.983,95%CI 2.487-14.397,p<0.001)与死亡率增加独立相关。在未接受抗真菌治疗和在曲霉阳性培养前后开始抗真菌治疗的 PA 患者中观察到显著的生存差异(p=0.001)。
住院 AECOPD 患者曲霉分离物主要提示 PA。PA 的 AECOPD 患者预后较曲霉定植患者差。经验性抗真菌治疗有望改善曲霉感染的预后。